Featured publications

  • Capmatinib in MET Exon 14-Mutated or MET-Amplified Non-Small-Cell Lung Cancer

    Authors: Wolf J, Seto T, Han JY, Reguart N, Garon EB, Groen HJM, Tan DSW, Hida T, de Jonge M, Orlov SV, Smit EF, Souquet PJ, Vansteenkiste J, Hochmair M, Felip E, Nishio M, Thomas M, Ohashi K, Toyozawa R, Overbeck TR, de Marinis F, Kim TM, Laack E, Robeva A, Le Mouhaer S, Waldron-Lynch M, Sankaran B, Balbin OA, Cui X, Giovannini M, Akimov M, Heist RS, GEOMETRY mono-1 Investigators.
    Reference: New England Journal Of Medicine 2020.

Featured Projects

  • PEERs: A phase II trial of Lenvatinib, pembrolizumab and carboplatin-etoposide in extended-small cell lung cancer. Includes translational exploratory research to identify biomarkers in tissue samples.

    Principal investigator: Noemi Reguart Aransay
    Code: 2020-005230-15
    Duration: 01/10/2020 - 01/10/2026
  • Validación de un Ensayo Multiplex Personalizado para la detección de Oncogenes y Firmas Inmunes en Cáncer de Pulmón (CP): Estudio Observacional, Prospectivo y Multicéntrico

    Principal investigator: Noemi Reguart Aransay
    Code: PI16/00890
    Duration: 01/01/2017 - 01/01/2019